Transient Cytolysis after Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma
Transarterial chemoembolization (TACE) is a minimally invasive radiological procedure which consists of infusing a chemotherapeutic agent in the main arterial supplier of the liver tumor, usually emulsion-based doxorubicin, followed by the occlusion of the involved vessel with 100–500 micron-sized e...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/12/10/1663 |
_version_ | 1797472155916566528 |
---|---|
author | Manuel Rodríguez-Perálvarez |
author_facet | Manuel Rodríguez-Perálvarez |
author_sort | Manuel Rodríguez-Perálvarez |
collection | DOAJ |
description | Transarterial chemoembolization (TACE) is a minimally invasive radiological procedure which consists of infusing a chemotherapeutic agent in the main arterial supplier of the liver tumor, usually emulsion-based doxorubicin, followed by the occlusion of the involved vessel with 100–500 micron-sized embolic particles [...] |
first_indexed | 2024-03-09T19:59:06Z |
format | Article |
id | doaj.art-8d77cfae2d714831b1b508b556a6d058 |
institution | Directory Open Access Journal |
issn | 2075-4426 |
language | English |
last_indexed | 2024-03-09T19:59:06Z |
publishDate | 2022-10-01 |
publisher | MDPI AG |
record_format | Article |
series | Journal of Personalized Medicine |
spelling | doaj.art-8d77cfae2d714831b1b508b556a6d0582023-11-24T00:50:00ZengMDPI AGJournal of Personalized Medicine2075-44262022-10-011210166310.3390/jpm12101663Transient Cytolysis after Transarterial Chemoembolization in Patients with Hepatocellular CarcinomaManuel Rodríguez-Perálvarez0Department of Hepatology and Liver Transplantation, Hospital Universitario Reina Sofía and IMIBIC, 14004 Córdoba, SpainTransarterial chemoembolization (TACE) is a minimally invasive radiological procedure which consists of infusing a chemotherapeutic agent in the main arterial supplier of the liver tumor, usually emulsion-based doxorubicin, followed by the occlusion of the involved vessel with 100–500 micron-sized embolic particles [...]https://www.mdpi.com/2075-4426/12/10/1663n/a |
spellingShingle | Manuel Rodríguez-Perálvarez Transient Cytolysis after Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma Journal of Personalized Medicine n/a |
title | Transient Cytolysis after Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma |
title_full | Transient Cytolysis after Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma |
title_fullStr | Transient Cytolysis after Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma |
title_full_unstemmed | Transient Cytolysis after Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma |
title_short | Transient Cytolysis after Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma |
title_sort | transient cytolysis after transarterial chemoembolization in patients with hepatocellular carcinoma |
topic | n/a |
url | https://www.mdpi.com/2075-4426/12/10/1663 |
work_keys_str_mv | AT manuelrodriguezperalvarez transientcytolysisaftertransarterialchemoembolizationinpatientswithhepatocellularcarcinoma |